Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Fusion Pharmaceuticals Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +1 vs. Q2 2023
- Shares held
- 49.9M
- −314.3K (−0.6%) vs. Q2 2023
- Total value
- $129.8M
- −$105.0M (−44.7%) vs. Q2 2023
- New holders
- 4
- 8 more added
- Sold out
- 3
- 9 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 10,683,789 | $27.8M | 0.07% | +50,000+0.5% | Added |
| Avidity Partners Management LP | 5,781,850 | $15.0M | 0.61% | +81,850+1.4% | Added |
| FMR LLC | 4,177,848 | $10.9M | 0.00% | −503,609−10.8% | Reduced |
| Johnson & Johnson | 3,670,516 | $9.54M | 3.52% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,122,770 | $8.12M | 0.19% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $8.10M | 0.01% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $7.66M | 2.68% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,823,000 | $7.34M | 0.16% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,751,395 | $7.15M | 0.24% | 00.0% | Unchanged |
| TPG GP A, LLC | 2,551,794 | $6.63M | 0.11% | 00.0% | Unchanged |
| Artal Group S.A. | 1,725,000 | $4.49M | 0.20% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4.06M | 1.62% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,354,258 | $3.52M | 0.85% | +25,000+1.9% | Added |
| 1832 Asset Management L.P. | 734,321 | $1.91M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 582,129 | $1.51M | 0.00% | +247,552+74.0% | Added |
| Eagle Health Investments LP | 579,769 | $1.51M | 0.33% | −100,601−14.8% | Reduced |
| Point72 Asset Management, L.P. | 328,868 | $855.1K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 274,568 | $713.9K | 0.01% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 246,036 | $639.7K | 0.20% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 243,287 | $632.5K | 0.31% | −169,412−41.0% | Reduced |
| Morgan Stanley | 166,060 | $431.8K | 0.00% | +28,449+20.7% | Added |
| Sofinnova Investments, Inc. | 117,099 | $304.5K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 93,309 | $242.6K | 0.00% | −651−0.7% | Reduced |
| Woodline Partners LP | 78,035 | $202.9K | 0.00% | +78,035 | New |
| Sectoral Asset Management Inc | 57,297 | $149.0K | 0.03% | 00.0% | Unchanged |
| Leonteq Securities AG | 35,000 | $91.0K | 0.01% | 00.0% | Unchanged |
| Forefront Analytics, LLC | 33,685 | $87.6K | 0.05% | +13,610+67.8% | Added |
| Two Sigma Advisers, LP | 32,100 | $83.5K | 0.00% | −33,300−50.9% | Reduced |
| Geode Capital Management, LLC | 30,868 | $80.3K | 0.00% | +494+1.6% | Added |
| NEOS Investment Management LLC | 17,493 | $45.5K | 0.01% | +17,493 | New |
| BlackRock Inc. | 8,253 | $21.5K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,204 | $11.0K | 0.00% | +2,365+128.6% | Added |
| Bank of America Corp | 1,547 | $4.02K | 0.00% | −778−33.5% | Reduced |
| Dorsey Wright & Associates | 878 | $2.28K | 0.00% | −4,011−82.0% | Reduced |
| TD Waterhouse Canada Inc. | 700 | $1.68K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 500 | $1.19K | 0.00% | +500 | New |
| Signaturefd, LLC | 300 | $789 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 139 | $361 | 0.00% | +139 | New |
| Cubist Systematic Strategies, LLC | 10 | $26 | 0.00% | −90−90.0% | Reduced |
| JPMorgan Chase & Co | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 79 | $0 | 0.00% | −1,322−94.4% | Reduced |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −31,154−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |